Chemo-immunotherapy based on immunogenic cell death (ICD) is a promising strategy for
cancer therapy. However, the effective ICD requires a high dosage of ICD stimulus, which …

Tumor immunotherapy has revolutionized the field of oncology treatments in recent years.
As one of the promising strategies of cancer immunotherapy, tumor immunogenic cell death …

The combination of chemotherapy with the immune checkpoint blockade (ICB) therapy is
bringing a tremendous hope in the treatment of malignant tumors. However, the treatment …

Despite the clear benefits demonstrated by immunotherapy, there is still an inevitable off-
target effect resulting in serious adverse immune reactions. In recent years, the research and …

Immunotherapy has exhibited enormous practice in the treatment of melanoma because of
the intrinsic properties of tumor. Tumor can downmodulate immune function via multiple …

Exploring a rational delivery system of integrating chemotherapy with immunotherapy to
broaden benefits of cancer immunochemotherapy is still under challenge. Herein, we …

Highlights•The immunogenic cell death (ICD) of cancer cells promotes immune
response.•Nanosized drug delivery systems can induce ICD.•Anti-cancer nanomedicines …

Immunogenic cell death (ICD) is a special pattern of tumor cell death, enabling to elicit tumor‐
specific immune response via the release of damage‐associated molecular patterns and …

We developed a custom-designed liposome carrier for codelivery of a potent immunogenic
cell death (ICD) stimulus plus an inhibitor of the indoleamine 2, 3-dioxygenase (IDO-1) …

Tumor-associated fibroblasts (TAFs) play an important role in tumor progression and
therapeutic response, especially in the immunosuppressive tumor microenvironment (TME) …